California State Teachers Retirement System (CalSTRS)’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-63,500
Closed -$290K 3192
2025
Q1
$290K Hold
63,500
﹤0.01% 2244
2024
Q4
$358K Buy
63,500
+7,046
+12% +$39.7K ﹤0.01% 2248
2024
Q3
$273K Sell
56,454
-1,739
-3% -$10.1K ﹤0.01% 2329
2024
Q2
$284K Buy
58,193
+4,558
+8% +$28.6K ﹤0.01% 2312
2024
Q1
$712K Sell
53,635
-3,912
-7% -$51.9K ﹤0.01% 1981
2023
Q4
$802K Buy
57,547
+8,056
+16% +$99.9K ﹤0.01% 1948
2023
Q3
$656K Sell
49,491
-2,744
-5% -$44.2K ﹤0.01% 2039
2023
Q2
$979K Buy
52,235
+5,085
+11% +$84.7K ﹤0.01% 1927
2023
Q1
$680K Sell
47,150
-159
-0.3% -$3.11K ﹤0.01% 2132
2022
Q4
$915K Buy
47,309
+1,647
+4% +$43.6K ﹤0.01% 1960
2022
Q3
$1.57M Buy
45,662
+13,540
+42% +$432K ﹤0.01% 1593
2022
Q2
$491K Buy
32,122
+2,130
+7% +$33K ﹤0.01% 2404
2022
Q1
$684K Buy
29,992
+7,269
+32% +$208K ﹤0.01% 2248
2021
Q4
$838K Buy
22,723
+14,185
+166% +$596K ﹤0.01% 2268
2021
Q3
$401K Buy
+8,538
New +$502K ﹤0.01% 2526

Other funds holding VERV

California State Teachers Retirement System (CalSTRS)'s VERV Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Verve Therapeutics (VERV) in Q2 2025, closing a stake of 63,500 shares — an estimated $290K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in VERV in Q3 2021 and held it in 15 quarters. The position peaked at $1.57M in Q3 2022. 175 funds tracked by Wall St. Rank hold VERV as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Verve Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 63,500 Verve Therapeutics shares in Q2 2025, an estimated $290K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Verve Therapeutics in Q3 2021 and held it in 15 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Verve Therapeutics position peaked at $1.57M in Q3 2022.
  • 175 funds tracked by Wall St. Rank held Verve Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.